Search - tctmd.com

Displaying 41 - 60 of 299

Sort: Relevancy | Date

Presentation THT 2025

Gene Therapy for HCM: Is a Cure Coming?

Presenter: Nosheen Reza

February 11, 2025

Presentation THT 2025

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Presenter: Anjali Owens

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Case-in-the-Box: SESAME

Presenter: Adam Greenbaum

February 11, 2025

Presentation THT 2025

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

Presenter: Alexander Smith

February 11, 2025

Presentation AHA 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presenter: John Sapp

November 16, 2024

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

After REVIVED: When and How Should I Revascularize Patients With Cardiomyopathy and Coronary Artery Disease?

Presenter: Margaret McEntegart

October 29, 2024

Presentation TCT 2024

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Presenter: Ann Gage

October 29, 2024

Presentation TCT 2024

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Presenter: CHANG HOON KIM

October 29, 2024

Presentation TCT 2024

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

Presenter: Sean Pinney

October 28, 2024

Presentation TCT 2024

TCT 669: Impact of Epilepsy on In-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy: A National Inpatient Sample Analysis

Presenter: Anusha Kavarthapu

October 27, 2024

Presentation TCT 2024

TCT 672: High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy Without Improvement in Outcomes Over the Years

Presenter: Mohammad Reza Movahed

October 27, 2024

Presentation TCT 2024

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

Presenter: Stanislav Fanta

October 27, 2024

Presentation TCT 2024

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Presenter: Himaja Dutt Chigurupati

October 27, 2024

Presentation TCT 2024

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Kylie Duckworth

October 27, 2024

Advertisement

Gene Therapy for HCM: Is a Cure Coming?

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Will Novel Catheter Based Approaches Save the Day?

Case-in-the-Box: SESAME

The Catecholaminergic Theory of Takotsubo in Action: A Case of Fulminant Stress Cardiomyopathy Rescued by ECPR in a Young Woman With Pheochromocytoma

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

After REVIVED: When and How Should I Revascularize Patients With Cardiomyopathy and Coronary Artery Disease?

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Controlled Pulmonary Banding for Dilated Cardiomyopathy: the Restore Medical Approach

TCT 669: Impact of Epilepsy on In-Hospital Outcomes in Patients With Takotsubo Cardiomyopathy: A National Inpatient Sample Analysis

TCT 672: High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy Without Improvement in Outcomes Over the Years

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content